DAFTAR PUSTAKA

1. Handel MV, Swaab H, De Vries LS, Jongmans MJ. Long term cognitive and behavioral
consequences of neonatal encephalopathy following perinatal asphyxia: a review.
European Journal Pediatric. 2007;166: 645-654.
2. Evans K, Rigby AS, Hamilton P, Titchner N, Hall DM. The relationship between neonatal
encephalopathy and cerebral palsy: a cohort study. J Obstet Gynaecol. 2001;21: 114–20.
3. Badawi N, Kurinczuk JJ, Keogh JM, Alessandri LM, O'Sullivan F, Burton PR, et al.
Intrapartum risk factors for newborn encephalopathy: the Western Australia case–control
study. Br Med J .1998;317: 1554–8.
4. Kurinczuk JJ, White-Koning M, Badawi N. Epidemiology of neonatal encephalopathy and
hypoksic ischemic encephalopathy. Early Human Development. 2010;86: 329-338.
5. Benedeto-Stojanov D, Stojanov D. Minimal Hepatik Encephalopaty. In: Editor Team
Faculty of Medicine University of Nis Serbia. Miscellanea on Encephalopaties—A Second
Look. Europe: InTech. 2010.
6. DiCarlo JV, Frankel LR. Neurologic Stabilization. In: Behrman RE, Kliegman RM, Jenson
HB. (eds.) Nelson TextBook of Pediatrics. 17th ed. Philadelphia: Saunders An Imprint of
Elsevier Science. 2004.
7. Atri A, Milligan TA, Reddy KC, Kayser AS. Encephalopathy: Approch to Diagnosis and
Care. Neurology. 2008;12: 1-2.
8. Lewis SL. Encephalopaty dalam Emergency Neurology. USA: Spingerlink; 2012. p283-
294.
9. Chandran L, Catalado R. Lead Poisoning: Basic and New Developments. Pediatrics in
Review. 2010;31(10):399-407.
10. Laish I, Ari ZB. Noncirrhotic hyperammonaemic encephalopathy. Journal of The
International Association for Study of The Liver. 2011; 1259-1270.
11. Tunkel AR, Glaser CA, Bloch KC, Sejvar JJ, Marra CM, Roose KL. et al. The
Management of Encephalitis: Clinical Practice Guidelines by the Infectious Diseases
Society of America. CID.2008;47(1): 303-327.
12. Kennedy PGE. Viral Encephalitis: Cause, Differential Diagnosis and Management.
Journal of Neurology Neurosurgery Psychiatry. 2004;75: i10-i15
13. Cotena S, Piazza O. Sepsis Associated Encephalopathy. Traditional Medicine. 2012;2(3):
20-27.
14. Papadopoulus MC, Cavies DC, Moss RF, Tighe D, Bennett ED. Encephalopathy. Critical
Care Medicine. 2000; 28(8): 3019-3024.
15. Olympio KPK, Goncalves C. Neurotoxicity and aggressiveness triggered by low level lead
in children: a review. Panam American Journal Public Health. 2009; 26(3): 266- 275.
16. Karii SK, Saper RB, Kales SN. Lead Encephalopathy Due to Traditional Medicines. Curr
Drug Saf. 2008;3(1): 54-59.
17. McCandless, D.W. Metabolic Encephalopathy. USA: Spinger Science. 2007.
18. Arya R, Gulati S, Deopujari S, Management of hepatik encephalopathy in children.
Postgraduation Medical Journal. 2010;86: 34-41.
19. Cash WJ, Mcconville P, Mcdermott E, Mccormick PA, Callender ME, McDougal NI.
Current concept in the assessment and treatment of Hepatik Encephalopathy. Q J Med.
2010;103: 9-16.
20. Gowen CW. Assessment of the Mother, Fetus and Newborn. In: Kliegman RM, Marcdante
KJ, Jenson HB, Behrman RE. (eds.) Essential of Pediatrics. 5th ed. Philadelphia: Saunders
An Imprint of Elsevier Science. 2007.